|
AMMECR1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.54140000003289E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.236520E-03 |
| Normal-vs-Stage2 |
8.384400E-02 |
| Normal-vs-Stage3 |
1.779250E-03 |
| Normal-vs-Stage4 |
1.414620E-01 |
| Stage1-vs-Stage2 |
4.589000E-01 |
| Stage1-vs-Stage3 |
6.437900E-02 |
| Stage1-vs-Stage4 |
6.779600E-01 |
| Stage2-vs-Stage3 |
6.070200E-01 |
| Stage2-vs-Stage4 |
7.756400E-01 |
| Stage3-vs-Stage4 |
4.049600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.61890000005549E-06 |
| Normal-vs-AfricanAmerican |
4.557900E-03 |
| Normal-vs-Asian |
9.832100E-02 |
| Caucasian-vs-AfricanAmerican |
6.130600E-01 |
| Caucasian-vs-Asian |
7.184600E-01 |
| AfricanAmerican-vs-Asian |
8.647000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.85880000000461E-05 |
| Normal-vs-Female |
9.04950000046867E-07 |
| Male-vs-Female |
1.441560E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.328000E-02 |
| Normal-vs-Extreme_Weight |
5.337900E-03 |
| Normal-vs-Obese |
6.48409999999267E-05 |
| Normal-vs-Extreme_Obese |
1.647570E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.344800E-01 |
| Normal_Weight-vs-Obese |
4.712000E-02 |
| Normal_Weight-vs-Extreme_Obese |
7.428200E-01 |
| Extreme_Weight-vs-Obese |
4.537900E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.267000E-01 |
| Obese-vs-Extreme_Obese |
4.395800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.555600E-04 |
| Normal-vs-Age(41-60Yrs) |
7.58799999500681E-08 |
| Normal-vs-Age(61-80Yrs) |
3.037300E-03 |
| Normal-vs-Age(81-100Yrs) |
2.511600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.266200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.861800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.734410E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.290100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.254400E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.758600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.55250000000162E-06 |
| Normal-VS-Type2 PRCC |
7.000200E-02 |
| Normal-VS-KIRP CIMP |
8.677100E-03 |
| Normal-VS-Unclassified PRCC |
3.588700E-04 |
| Type1 PRCC-VS-Type2 PRCC |
3.863700E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.071190E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.613440E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.816080E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
1.173610E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
5.398000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.140200E-02 |
| Normal-vs-N1 |
1.960550E-04 |
| Normal-vs-N2 |
1.651650E-02 |
| N0-vs-N1 |
1.556100E-03 |
| N0-vs-N2 |
3.120200E-01 |
| N1-vs-N2 |
3.482400E-01 |
|
|
